273 related articles for article (PubMed ID: 19365835)
21. Non-Hodgkin Lymphoma of the Liver: A US Population-based Analysis.
El-Fattah MA
J Clin Transl Hepatol; 2017 Jun; 5(2):83-91. PubMed ID: 28660145
[No Abstract] [Full Text] [Related]
22. Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study.
Váróczy L; Gergely L; Zeher M; Szegedi G; Illés A
Rheumatol Int; 2002 Nov; 22(6):233-7. PubMed ID: 12426661
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology and etiology of diffuse large B-cell lymphoma.
Wang SS
Semin Hematol; 2023 Nov; 60(5):255-266. PubMed ID: 38242772
[TBL] [Abstract][Full Text] [Related]
24. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
25. Presence of autoimmune disease affects not only risk but also survival in patients with B-cell non-Hodgkin lymphoma.
Kleinstern G; Averbuch M; Abu Seir R; Perlman R; Ben Yehuda D; Paltiel O
Hematol Oncol; 2018 Apr; 36(2):457-462. PubMed ID: 29469175
[TBL] [Abstract][Full Text] [Related]
26. Non-Hodgkin lymphoma and autoimmunity: does gender matter?
Ansell P; Simpson J; Lightfoot T; Smith A; Kane E; Howell D; Newton R; McGonagle D; Jack A; Roman E
Int J Cancer; 2011 Jul; 129(2):460-6. PubMed ID: 20853323
[TBL] [Abstract][Full Text] [Related]
27. Autoimmune disease-associated non-Hodgkin's lymphoma-a large retrospective study from China.
Hu S; Zhou D; Wu Y; Zhao Y; Wang S; Han B; Duan M; Li J; Zhu T; Zhuang J; Cao X; Cai H; Feng J; Zhang Y; Zhang F; Zeng X; Zhao Y; Wang Q; Zhang W
Ann Hematol; 2019 Feb; 98(2):445-455. PubMed ID: 30370485
[TBL] [Abstract][Full Text] [Related]
28. Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma.
Hollander P; Rostgaard K; Smedby KE; Chang ET; Amini RM; de Nully Brown P; Glimelius B; Adami HO; Melbye M; Glimelius I; Hjalgrim H
Am J Epidemiol; 2015 Oct; 182(7):624-32. PubMed ID: 26346543
[TBL] [Abstract][Full Text] [Related]
29. A Rare Combination of Gastric Mucosa-associated Lymphoid Tissue Lymphoma, Autoimmune Gastritis, Thyroiditis, Hemolysis, and Systemic Lupus Erythematosus.
Kotera T; Itani K; Uchiyama H; Takemoto T; Ooyama K; Hirata K; Imashuku S; Nakajima S
Intern Med; 2020; 59(1):61-65. PubMed ID: 31902909
[TBL] [Abstract][Full Text] [Related]
30. Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006.
van Leeuwen MT; Turner JJ; Joske DJ; Falster MO; Srasuebkul P; Meagher NS; Grulich AE; Giles GG; Vajdic CM
Int J Cancer; 2014 Nov; 135(9):2146-56. PubMed ID: 24639369
[TBL] [Abstract][Full Text] [Related]
31. Erythrocyte levels of cadmium and lead and risk of B-cell non-Hodgkin lymphoma and multiple myeloma.
Deubler EL; Gapstur SM; Diver WR; Gaudet MM; Hodge JM; Stevens VL; McCullough ML; Haines LG; Levine KE; Teras LR
Int J Cancer; 2020 Dec; 147(11):3110-3118. PubMed ID: 32506449
[TBL] [Abstract][Full Text] [Related]
32. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
Zintzaras E; Voulgarelis M; Moutsopoulos HM
Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
[TBL] [Abstract][Full Text] [Related]
33. Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype.
Fallah M; Liu X; Ji J; Försti A; Sundquist K; Hemminki K
Ann Oncol; 2014 Jul; 25(7):1397-1404. PubMed ID: 24718892
[TBL] [Abstract][Full Text] [Related]
34. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study.
Engels EA; Cerhan JR; Linet MS; Cozen W; Colt JS; Davis S; Gridley G; Severson RK; Hartge P
Am J Epidemiol; 2005 Dec; 162(12):1153-61. PubMed ID: 16251389
[TBL] [Abstract][Full Text] [Related]
35. A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study.
Löfström B; Backlin C; Sundström C; Ekbom A; Lundberg IE
Ann Rheum Dis; 2007 Dec; 66(12):1627-32. PubMed ID: 17517757
[TBL] [Abstract][Full Text] [Related]
36. Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes.
Simard JF; Baecklund F; Chang ET; Baecklund E; Hjalgrim H; -Olov Adami H; Glimelius B; Smedby KE
Int J Cancer; 2013 Jun; 132(11):2659-66. PubMed ID: 23160780
[TBL] [Abstract][Full Text] [Related]
37. History of autoimmune conditions and lymphoma prognosis.
Kleinstern G; Maurer MJ; Liebow M; Habermann TM; Koff JL; Allmer C; Witzig TE; Nowakowski GS; Micallef IN; Johnston PB; Inwards DJ; Thompson CA; Feldman AL; Link BK; Flowers C; Slager SL; Cerhan JR
Blood Cancer J; 2018 Aug; 8(8):73. PubMed ID: 30069001
[TBL] [Abstract][Full Text] [Related]
38. Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study.
Landgren O; Linet MS; McMaster ML; Gridley G; Hemminki K; Goldin LR
Int J Cancer; 2006 Jun; 118(12):3095-8. PubMed ID: 16395700
[TBL] [Abstract][Full Text] [Related]
39. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
Smedby KE; Baecklund E; Askling J
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2069-77. PubMed ID: 17119030
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune conditions and pancreatic cancer risk in older American adults.
Yuan F; Pfeiffer RM; Julián-Serrano S; Arjani S; Barrett MJ; Koshiol J; Stolzenberg-Solomon RZ
Int J Cancer; 2023 Jan; 152(2):172-182. PubMed ID: 36059225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
